The CREST team in TU Dublin were delighted to have two projects approved for funding under the Disruptive Technologies Fund (DTIF) last week.
The Tánaiste and Minister for Enterprise, Trade and Employment, Leo Varadkar TD, the Minister for Further and Higher Education, Research, Innovation and Science, Simon Harris TD and the Minister of State for Trade Promotion, Digital and Company Regulation, Robert Troy TD, made the announcement last week.
Crannmed leads the first project in partnership with Innovative Catheter Solutions (ICS), Creganna (all based in Galway) and CREST in TU Dublin. The project aims to develop a treatment for chronic knee osteoarthritis to deliver dramatic pain and mobility benefits to patients. The €2.47m project results from over three years of collaborative research and builds on existing joint patents filed by Crannmed and CREST.
The second project is led by Prelude Medical (Galway) with Theradep (Tipperary) and CREST in TU Dublin. The €2.89m project RELAY will develop and commercialise a disruptive large-bore vascular closure device that will become the new standard of care for catheter-based surgeries. The consortium has achieved interesting results to date and believes that the project will deliver new state-of-the-art closure devices for ruptured arteries.
Both projects have been based on collaborative research with the CREST Medical Device Team, which has also received funding from the Enterprise Ireland Capital Equipment Call. One piece of equipment funded, a Nanoscratch tester and profilometer will enable the team to examine catheters being used in the human body.
CREST is working on another DTIF project (E-Bambi) investigating bioactive coatings on 3-D printed metal parts with SEAM (WIT), Stryker Orthopaedic (Cork), Schivo Medical (Waterford) and Graph Engineering (Dublin).
More information about the Disruptive Technologies Fund is available here.